7.54xsubscribed
Sai Life Sciences IPO
7.54xsubscribed
Pharmaceuticals & Drugs
listed
7.54xsubscribed
₹14,094Min. investment
Sai Life Sciences Limited IPO Details
Sector
Pharmaceuticals & Drugs
Issue size
₹3,042Cr
IPO type
Mainboard
Market cap
₹11,418.6CrHigher than sector avg
Price range
₹522 – ₹549
RevenueApr 2023 - Mar 2024
₹1,465.1CrHigher than sector avg
Listing date
18 Dec 2024
Lot size
27 shares
Red Herring Prospectus
Read
Growth rate3Y CAGR
19.00%
SectorPharmaceuticals & Drugs
Price range₹522 – ₹549
IPO type
Regular
Lot size27 shares
Issue size₹3,042Cr
Red Herring Prospectus
Read
Market cap
₹11,418.6CrHigher than sector avg
RevenueApr 2023 - Mar 2024
₹1,465.1CrHigher than sector avg
Growth rate3Y CAGR
19.00%
Sai Life Sciences IPO Timeline
- Pre-apply10 Dec 2024
- Bid start11 Dec 2024
- Bid end13 Dec 2024
- Allotment16 Dec 2024
- Release of funds17 Dec 2024
- Demat transfer17 Dec 2024
- Listing18 Dec 2024
About Sai Life Sciences Limited
Sai Life Sciences Limited is a contract research, development, and manufacturing organisation (CRDMO) founded in 1999. The company provides end-to-end services across the drug discovery, development, and manufacturing value chain to global pharmaceutical and biotechnology companies. The company’s CRO and CDMO services span early drug discovery, clinical trial support, and commercial drug manufacturing, with a portfolio of 170+ innovator pharmaceutical products. In FY24, revenue from CRO business made up 33.85% of total revenue, while the rest was contributed by the company’s CDMO business. Meanwhile, revenue from its top ten customers made up 46.2% of overall revenue.
Checklist
Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial
health at a glance and identify quality investment opportunities easily
Objectives of Sai Life Sciences IPO
Debt Repayment
The company will use the net proceeds worth ₹720 crore to repay/prepay, in fullGeneral Corporate Purpose
Company will use part of the IPO proceeds for general cooprate purposes.Offer For Sale
Part of the IPO proceeds worth ₹2,092.6 crore will go to selling shareholders.
Compare
Companies in this sector
Sun Pharmaceutical Industries Ltd
Divi's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Sai Life Sciences IPO Contact Details
Company NameSai Life Sciences Limited
How to apply for Sai Life Sciences IPO?
- Step 1
Log in to your Upstox account to access IPO investments. Next, select the current IPO section.
- Step 2
Specify IPO details. Enter the number of lots and the price you wish to apply for.
- Step 3
Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.
- Step 4
Mandate Notification. Your UPI app will receive a mandate notification to block funds.
- Step 5
Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.


